Amneal Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AMRX Nasdaq 2830 www.amneal.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Amneal Pharmaceuticals, Inc.

Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi‑Year Share Price Run - Jan 14th, 2026 4:09 am
Amneal Pharmaceuticals Eyes 2026 Growth at JPMorgan, Crexont Sales Seen Doubling in 2025 - Jan 13th, 2026 7:04 pm
Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14 - Jan 10th, 2026 12:57 pm
KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease - Jan 9th, 2026 9:00 am
Can This Healthcare Stock Keep Going After a Nearly 70% Surge? - Jan 7th, 2026 12:55 pm
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Multi Year Shareholder Returns - Jan 6th, 2026 6:05 am
How Recent Q3 Beats And FDA Wins Are Shaping The Amneal Pharmaceuticals (AMRX) Story - Jan 5th, 2026 8:10 pm
1 Profitable Stock with Exciting Potential and 2 Facing Headwinds - Jan 4th, 2026 9:35 pm
Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® - Dec 22nd, 2025 2:01 pm
mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA® - Dec 22nd, 2025 2:00 pm
1 Small-Cap Stock to Target This Week and 2 That Underwhelm - Dec 17th, 2025 9:31 pm
Three Insider-Favored Growth Companies To Watch - Dec 17th, 2025 4:35 am
Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals - Dec 9th, 2025 2:01 pm
Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease - Dec 5th, 2025 6:00 am
How Back-to-Back RESTASIS and PROAIR Generics At Amneal Pharmaceuticals (AMRX) Has Changed Its Investment Story - Dec 3rd, 2025 7:11 pm
3 Healthcare Stocks We’re Skeptical Of - Dec 2nd, 2025 9:32 pm
Amneal to Participate in Upcoming Investor Conferences - Dec 2nd, 2025 6:00 am
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol - Dec 2nd, 2025 6:00 am
Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% - Dec 1st, 2025 2:01 pm
Looking at the Narrative for Amneal as Analyst Targets Shift After Recent Milestones - Nov 30th, 2025 12:09 am